EP1003493A4 - Use of selective rxr agonists to prevent surgical adhesions - Google Patents
Use of selective rxr agonists to prevent surgical adhesionsInfo
- Publication number
- EP1003493A4 EP1003493A4 EP98938064A EP98938064A EP1003493A4 EP 1003493 A4 EP1003493 A4 EP 1003493A4 EP 98938064 A EP98938064 A EP 98938064A EP 98938064 A EP98938064 A EP 98938064A EP 1003493 A4 EP1003493 A4 EP 1003493A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- surgical adhesions
- rxr agonists
- prevent surgical
- selective rxr
- selective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5401797P | 1997-07-29 | 1997-07-29 | |
US54017P | 1997-07-29 | ||
PCT/US1998/015625 WO1999006036A1 (en) | 1997-07-29 | 1998-07-28 | Use of selective rxr agonists to prevent surgical adhesions |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1003493A1 EP1003493A1 (en) | 2000-05-31 |
EP1003493A4 true EP1003493A4 (en) | 2002-03-27 |
Family
ID=21988221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98938064A Withdrawn EP1003493A4 (en) | 1997-07-29 | 1998-07-28 | Use of selective rxr agonists to prevent surgical adhesions |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1003493A4 (en) |
JP (1) | JP2001511445A (en) |
AU (1) | AU733236B2 (en) |
CA (1) | CA2295807A1 (en) |
WO (1) | WO1999006036A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6624154B1 (en) * | 1999-04-23 | 2003-09-23 | Bristol-Myers Squibb Company | Compositions and methods for treatment of hyperproliferative diseases |
WO2007029760A1 (en) * | 2005-09-09 | 2007-03-15 | R & R Inc. | Pharmaceutical for use in prevention and/or treatment of bowel disease |
JP5055971B2 (en) | 2006-11-16 | 2012-10-24 | 株式会社ニコン | Surface treatment method, surface treatment apparatus, exposure method, exposure apparatus, and device manufacturing method |
JP2008179570A (en) * | 2007-01-25 | 2008-08-07 | R&R Inc | Medicine for preventing and/or treating internal organ adhesion |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993021146A1 (en) * | 1992-04-22 | 1993-10-28 | Ligand Pharmaceuticals Incorporated | Compounds having selectivity for retinoid x receptors |
WO1994012880A2 (en) * | 1992-11-25 | 1994-06-09 | La Jolla Cancer Research Foundation | Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
EP0694301A1 (en) * | 1994-07-27 | 1996-01-31 | Centre International De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) | Synergistic combination containing at least a RXR specific ligand and a RAR alpha specific ligand |
US5534261A (en) * | 1995-01-17 | 1996-07-09 | University Of Southern California | Retinoid-based compositions and method for preventing adhesion formation using the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5455265A (en) * | 1993-02-11 | 1995-10-03 | Allergan, Inc. | Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors |
US5399586A (en) * | 1993-03-11 | 1995-03-21 | Allergan, Inc. | Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity |
-
1998
- 1998-07-28 JP JP2000504850A patent/JP2001511445A/en active Pending
- 1998-07-28 CA CA002295807A patent/CA2295807A1/en not_active Abandoned
- 1998-07-28 WO PCT/US1998/015625 patent/WO1999006036A1/en not_active Application Discontinuation
- 1998-07-28 EP EP98938064A patent/EP1003493A4/en not_active Withdrawn
- 1998-07-28 AU AU86670/98A patent/AU733236B2/en not_active Ceased
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993021146A1 (en) * | 1992-04-22 | 1993-10-28 | Ligand Pharmaceuticals Incorporated | Compounds having selectivity for retinoid x receptors |
WO1994012880A2 (en) * | 1992-11-25 | 1994-06-09 | La Jolla Cancer Research Foundation | Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
EP0694301A1 (en) * | 1994-07-27 | 1996-01-31 | Centre International De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) | Synergistic combination containing at least a RXR specific ligand and a RAR alpha specific ligand |
US5534261A (en) * | 1995-01-17 | 1996-07-09 | University Of Southern California | Retinoid-based compositions and method for preventing adhesion formation using the same |
Non-Patent Citations (1)
Title |
---|
See also references of WO9906036A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1999006036A1 (en) | 1999-02-11 |
CA2295807A1 (en) | 1999-02-11 |
AU733236B2 (en) | 2001-05-10 |
AU8667098A (en) | 1999-02-22 |
EP1003493A1 (en) | 2000-05-31 |
JP2001511445A (en) | 2001-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL134851A0 (en) | Prostaglandin agonists and their use to treat bone disorders | |
PL298493A1 (en) | Surgical clip | |
HK1026699A1 (en) | Crystalline form of omeprazole sodium salt | |
HUP0002493A3 (en) | Use of colchinol derivatives as vascular damaging agents and certain new compounds | |
IL126592A0 (en) | The use of mmp-13 selective inhibitors for the treatment of osteoarthritis and other mmp-mediated disorders | |
PL333918A1 (en) | Derivatives of 6-phenylpyryidil-2-amine useful as nos inhibitors | |
GB9722203D0 (en) | Surgical clip | |
EG23980A (en) | Potassium salt of (s)-omeprazole | |
PT1073416E (en) | Use of inhaled no as anti-inflammatory agent | |
ZA957187B (en) | Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments | |
GB9807464D0 (en) | Purification of human acid µ-glucosidase | |
HUP0203295A3 (en) | Treatment of emphysema using pharmaceutical compositions containing rar selective retinoid agonists | |
ZA957113B (en) | Use of N-substituted pyhenothiazines | |
GB9418762D0 (en) | Use of substituted cyclopentane-DI-and-triones | |
HU9700071D0 (en) | Use of muramilpeptides | |
IL113992A0 (en) | Use of copolymer-1 | |
ZA96725B (en) | Use of phenyclyclohexylcarboxamides | |
EP1003493A4 (en) | Use of selective rxr agonists to prevent surgical adhesions | |
HUP0003845A3 (en) | Use of 8a-azalides as antimicrobial agents | |
GB9525828D0 (en) | Use of hetarylacetic acid derivatives | |
EP1005340A4 (en) | Retinoid antagonists for prevention of surgical adhesions | |
GB9810127D0 (en) | Prevention of surgical adhesions | |
ZA952405B (en) | Solutions of dirithromycin | |
GB2311723B (en) | Sanitary unit free of ligature points | |
EP0845990A4 (en) | New use of pregnane-diones as analgesic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000215 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020208 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 31/07 A, 7A 61K 31/38 B, 7A 61K 31/335 B, 7A 61K 31/385 B, 7A 61K 31/39 B, 7A 61K 31/19 B |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61P 41/00 B Ipc: 7A 61K 31/19 B Ipc: 7A 61K 31/39 B Ipc: 7A 61K 31/385 B Ipc: 7A 61K 31/335 B Ipc: 7A 61K 31/38 B Ipc: 7A 61K 31/07 A |
|
RTI1 | Title (correction) |
Free format text: USE OF SELECTIVE RXR AGONISTS TO PREVENT SURGICAL ADHESIONS |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61P 41/00 B Ipc: 7A 61K 31/19 B Ipc: 7A 61K 31/39 B Ipc: 7A 61K 31/385 B Ipc: 7A 61K 31/335 B Ipc: 7A 61K 31/38 B Ipc: 7A 61K 31/07 A |
|
RTI1 | Title (correction) |
Free format text: USE OF SELECTIVE RXR AGONISTS TO PREVENT SURGICAL ADHESIONS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040610 |